Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Pharmacy Archives
Print | Email | Share | Comments (1)

NeuroMetrix and Nipro Team Up to Market Neuropathy Test


Jul 16, 2011

Nipro Diagnostics, Inc., and NeuroMetrix, Inc., Have Announced That They Will Seek Opportunities

Nipro Diagnostics, Inc., and NeuroMetrix, Inc., have announced that they will seek opportunities to sell their soon-to-be-introduced NC-stat® DPNCheckTM neuropathy test in retail medical clinics nationwide. The test, conducted onsite, evaluates neuropathies, including diabetic peripheral neuropathy (DPN).

DPN, which affects more than half of all people with diabetes, is a condition in which the lower limbs lose sensation. Lack of ability to perceive injuries, as well as the slower healing process brought on by diabetes, can result in stubborn foot ulcers that lead to amputation.

The companies are hoping that the test will provide an accessible, cost-effective approach to detecting DPN and other neuropathic conditions. Their target market, retail medical clinics, is one of the fastest growing  provider segments of the healthcare system. Nipro and NeuroMetrix estimate that there are now 1,200 such clinics operating in the United States, a figure that is growing at a double-digit annual rate.  

Often located alongside chain drug store and department store pharmacies, retail medical clinics offer urgent, convenient medical care, including vaccinations, treatment of minor injuries and chronic conditions, and diagnostic procedures such as blood tests. Many clinics are beginning to provide expanded services for certain disease states such as diabetes.

Florida-based Nipro Diagnostics, a subsidiary of Japan-based Nipro Corporation, manufactures and markets blood glucose monitoring systems, including private-label lines. Massachusetts-based NeuroMextrix develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve disorders.

 


Categories: Amputations & Amputee, Blood Glucose, Diabetes, Diabetes, Diabetic, Diagnosis, Foot ulcers, Medical Information, Monitoring, Pharmacist, Pharmacy



You May Also Be Interested In...


Comments

Posted by bhaskar on 16 July 2011

Will the diabetic neuropathy test will both tell the recipients about positive & negative results? Will this test be offered by health insurance as a routine test and will have connection to A1C, Type I & II diabetes, no of years with diabetes?


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.